Center-Authored Papers
Filters: Author is Holmberg, Leona [Clear All Filters]
Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center.. Bone marrow transplantation. 47(10):1312-7. Abstract
.
2012.
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.. British journal of haematology. 162(5):648-56. Abstract
.
2013.
.
2015.
Busulfan in hematopoietic stem cell transplant setting.. Expert opinion on drug metabolism & toxicology. 5(8):957-69. Abstract
.
2009.
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(12):1765-74. Abstract
.
2011.
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.. Leukemia & lymphoma. 49(6):1062-73. Abstract
.
2008.
The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cells.. Journal of clinical apheresis. 27(2):81-7. Abstract
.
2012.
Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
.
2016.
High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.. Leukemia & lymphoma. 49(10):1899-906. Abstract
.
2008.
.
2008.
.
2017.
Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
.
2016.
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(22):3023-9. Abstract
.
2011.
Multiple Myeloma, Version 2.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(11):1398-435. Abstract
.
2015.
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(4):389-400. Abstract
.
2016.
Panobinostat: a review of trial results and future prospects in multiple myeloma.. Expert review of hematology. 8(1):9-18. Abstract
.
2015.
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(10):1893-1899. Abstract
.
2016.
.
2007.
.
2013.
Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(3):395-402. Abstract
.
2010.
The role of autologous and allogeneic hematopoietic stem cell transplantation for Hodgkin lymphoma.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(9):1060-71. Abstract
.
2011.
Salvage Second Hematopoietic Cell Transplantation in Myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
.
2013. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)